Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ryan M. Kwok"'
Publikováno v:
Albanian Journal of Trauma and Emergency Surgery, Vol 3, Iss 1 (2019)
Cirrhosis describes the end stages of chronic inflammation and progressive scarring of the liver and may lead to hepatocellular dysfunction and portal venous hypertension. Liver cirrhosis in itself is a major cause of mortality worldwide, accounting
Externí odkaz:
https://doaj.org/article/ac6dd7a014a445f19b49c2c13a284ba3
Autor:
David C. Mulligan, Elizabeth C. Verna, Hugo R. Rosen, Ryan M. Kwok, Brendan M. McGuire, Jaime Chu, Oren K Fix, Raymond T. Chung, Emily A. Blumberg, Nancy Reau, Kyong-Mi Chang, Bilal Hameed, Jennifer C. Price, Elizabeth Goacher, Andrew Reynolds, Michael L. Schilsky, Robert J. Fontana, Mark W. Russo, Laura Kulik, K. Rajender Reddy, Daniel R. Kaul, John W. Ward
Publikováno v:
Hepatology
The aim of this document is to provide a concise scientific review of the currently available COVID-19 vaccines and those in development, including mRNA, adenoviral vectors, and recombinant protein approaches. The anticipated use of COVID-19 vaccines
Publikováno v:
Current hepatology reports. 21(2)
The COVID-19 pandemic has resulted in over 800,000 deaths worldwide and resulted in fundamental changes in practice in nearly every aspect of medicine. The majority of symptomatic patients experience liver-associated enzyme (LAE) elevations which app
Autor:
Daniel S. Pratt, Elizabeth C. Verna, Jorge A. Bezerra, Ryan M. Kwok, Rohit Loomba, Oren K. Fix, Raymond T. Chung, K. Rajender Reddy, Michael L. Schilsky, Mark W. Russo, David C. Mulligan, Brendan M. McGuire, David E. Cohen, Robert J. Fontana, Bilal Hameed
Publikováno v:
Hepatology (Baltimore, Md.), vol 72, iss 1
Hepatology
Hepatology (Baltimore, Md.)
Hepatology
Hepatology (Baltimore, Md.)
Background and aims Coronavirus disease 2019 (COVID-19), the illness caused by the SARS-CoV-2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ba67fefc746f00b3bcfaa19b3210ec
https://escholarship.org/uc/item/5497145t
https://escholarship.org/uc/item/5497145t
Publikováno v:
Clinical Gastroenterology and Hepatology. 16:1003-1006
Publikováno v:
American Journal of Gastroenterology. 116:S1084-S1084
Publikováno v:
Hepatology Communications
Despite an unmet need for hepatologists in the United States, every year transplant hepatology (TH) fellowship positions remain unfilled. To address this, we investigated factors that influence trainee decisions about pursuing a career in hepatology.
Autor:
Tram T. Tran, Ryan M. Kwok
Publikováno v:
Current Treatment Options in Gastroenterology. 15:305-315
Chronic hepatitis C (HCV) is a hepatotropic virus which, when untreated, can lead to progressive inflammation and fibrosis resulting in cirrhosis, hepatocellular carcinoma (HCC), and decompensations related to end-stage liver disease. The relatively
Autor:
Ryan M. Kwok, Tram T. Tran
Publikováno v:
Clinics in Liver Disease. 20:693-702
Chronic hepatitis B infection (CHB) is a known risk factor for malignancy. Unlike hepatocellular carcinoma (HCC), less is known about the risk of non-HCC malignancy. However, epidemiology and pathologic evidence suggests a strong association between
Autor:
Suzanne Robertazzi, Andrea D. Branch, Helen S. Te, Coleman Smith, Michelle Lee Sang, Colleen Rodigas, Thomas D. Schiano, Janet Gripshover, Amber Tierney, Neal Patel, Mohamed Hassan, Darryn Potosky, Rohit Satoskar, Ryan M. Kwok, Joshua J Wiegel, Joseph Ahn
Publikováno v:
Liver Transplantation. 22:1536-1543
Hepatitis C virus (HCV) recurrence after liver transplant (LT) is associated with worse outcomes. Ledipasvir and sofosbuvir (LDV/SOF) has been approved for HCV treatment after LT, but there is limited data on the effectiveness and safety of LDV/SOF i